Retatrutide: What the New Triple Agonist Drug Means for Weight Loss and Diabetes Treatment
Retatrutide (LY3437943) is a first-in-class triple agonist medication that simultaneously activates three hormone receptors to treat obesity and type 2 diabetes, showing weight loss results of up to 24% in…